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Abstract
Background: Acute kidney injury due to glomerular bleeding has been described with IgA nephropathy and
supratherapeutic warfarin anticoagulation. There is usually demonstrable tubular obstruction by erythrocyte casts
associated with acute tubular injury. Although severe thrombocytopaenia increases the risk of bleeding, most cases
of haematuria have been ascribed to non-glomerular or urological bleeding without a direct link to acute kidney
injury. We describe a patient with acute kidney injury due to glomerular bleeding and tubular injury related to
severe thrombocytopaenia, who was subsequently found to have thin basement membrane disease.
Case presentation: A 56 year old man presented with macroscopic haematuria, acute kidney injury and a platelet
count of 35 × 109/L, in the absence of anticoagulation. Urinalysis demonstrated an active urinary sediment. His
kidney biopsy demonstrated extensive intraluminal erythrocyte casts associated with acute tubular injury, along
with haemosiderin deposition suggestive of recurrent glomerular bleeding. There was no histological evidence of
glomerular pathology but electron microscopy analysis demonstrated thin basement membrane disease and
effacement of podocyte foot processes. During long term follow-up, thrombocytopaenia and intermittent
haematuria persisted. At 9 months, the patient progressed to Stage 5 chronic kidney disease with the development
of gross renal atrophy.
Conclusion: Recurrent macroscopic haematuria may be a risk factor for progressive renal injury in patients with
thin basement membrane. The mechanism may be due to recurrent acute kidney injury from glomerular bleeding
leading to repeated tubular damage. In the absence of anticoagulation, severe thrombocytopaenia may be a risk
factor for heavy glomerular bleeding and acute kidney injury in these patients.
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Background
The development of acute kidney injury (AKI) due to
glomerular haemorrhage has been described in patients
with IgA nephropathy and warfarin over-anticoagulation
[1, 2]. The latter has been termed warfarin-related ne-
phropathy. Patients often report macroscopic haema-
turia and the mechanism of injury is thought to be
intraluminal tubular obstruction by erythrocyte casts
and toxic injury from haemoglobin breakdown products
[1]. Severe thrombocytopenia has also been associated
with haematuria but the majority of reports indicate a
non-glomerular (urological) origin which does not dir-
ectly cause AKI. We report a patient who developed
AKI in the setting of glomerular haematuria precipitated
by thrombocytopenia, who was subsequently found to
have thin basement membrane disease.
Case presentation
A 56-year old man presented to a regional hospital with
acute gout of the right knee, on a background of
6 months of lethargy, easy bruising, epistaxis and recent
episodes of macroscopic haematuria. On presentation,
he was noted to have AKI, anaemia, thrombocytopaenia
and abnormal liver function tests. His past medical his-
tory included gout, alcoholism (10 standard drinks
daily), gastro-oesophageal reflux and previous gastric
fundoplication. He was not on any regular medications.
He lived alone and was an active smoker of 20 pack-
years but denied intravenous or recreational drugs. He
reported no fever, sweats or weight loss (body mass
index, 22.9 kg/m2). He had no haemodynamic com-
promise and was transferred to our centre for further
management.
On arrival, his blood pressure was 140/80 mmHg. He
had a normal mental status and no focal neurological
signs. Physical examination was notable for mild hepato-
megaly, subcutaneous bruising and spider naevi. Macro-
scopic haematuria was evident when the patient voided.
His vital signs were normal and the laboratory results on
arrival are shown in Table 1. The blood film showed tar-
get cells, anisocytosis, stomatocytes, occasional myelo-
cytes and confirmed thrombocytopaenia. In retrospect,
thrombocytopaenia was first noted eight months prior
to presentation (platelet count, 60 × 106/L; reference
range [RR], 150–400 × 106/L). At this time, the patient’s
serum creatinine was 100 μmol/L (RR, 60–110 μmol/L),
with an estimated glomerular filtration rate (eGFR) of
73 ml/min. Kidney function was noted to be slightly
impaired (serum creatinine, 113 umol/L (eGFR,
63 ml/min) four months ago, after the onset of haema-
turia was noted.
Autoimmune studies were negative including: anti-
nuclear, anti-extractable nuclear antigens, anti-neutrophil
cytoplasmic, anti-glomerular basement membrane,
anti-double stranded DNA antibodies. The serum
electrophoresis revealed neither serum paraprotein
nor increased free light chains. Serology was negative
for hepatitis B, C and HIV. Serum IgA level was ele-
vated at 6.7 g/L (RR, 0.80–4.50 g/L) with normal IgG
and IgM levels. Serum complement was low on pres-
entation, with a C3 of 0.56 g/L (RR, 0.79–1.52 g/L)
and C4 of 0.10 (RR, 0.16–0.38 g/L). Blood cultures
were negative on two separate occasions.
Urinalysis of a sterile, mid-stream sample confirmed
haematuria, with an erythrocyte count >999× 106/L
(RR, <13 × 106/L) and leukocyte count of 10 × 106/L
(RR, <10 × 106/L). Urine sediment analysis showed
Table 1 Laboratory parameters
Parameter Patient value Reference
Haemoglobin (g/L) 73 130–180
White cells ( × 109/L) 5.8 4.0–11.0
Plateletes ( × 109/L) 35 150–450
Neutrophils ( × 109/L) 2.93 2.00–8.00
Lymphocytes ( × 109/L) 1.83 1.00–4.00
Eosinophils ( × 109/L) 0.04 0.00–0.50
Reticulocytes (%) 2.8 0.3–2.5
Reticulocyte count ( × 109/L) 59 20–110
International normalised ratio (ratio) 1.2 0.8–1.2
Activated thromboplastin time (seconds) 27 22–32
Fibrinogen (g/L) 2.8 1.5–4.0
D-dimer (mg/L) 0.12 0.00–0.20
Haptoglobin (g/L) 1.18 0.36–1.95
Lactate dehydrogenase (U/L) 157 100–200
Direct anti-globulin test Negative
C-reactive protein (mg/L) 0.6 0.0-5.0
Sodium (mmol/L) 134 135–145
Potassium (mmol/L) 3.8 3.5–4.5
Chloride (mmol/L) 105 101–111
Bicarbonate (mmol/L) 22 22–32
Urea (mmol/L) 17.6 2.5–9.6
Creatinine (μmol/L) 260 55–105
Calcium (mmol/L) 2.15 2.20–2.60
Magnesium (mmol/L) 0.67 0.74–1.03
Phosphate (mmol/L) 1.36 0.80–1.50
Albumin (g/L) 28 35–45
Alkaline phosphatase (U/L) 112 30–120
Alanine transaminase (U/L) 42 7–56
γ-glutamyl transferase (U/L) 203 7–64
Vitamin B12 (pmol/L) 494 140–670
Red cell folate (nmol/L) 3110 >800
Uric acid (mmol/L) 0.66 0.24–0.50
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dysmorphic erythrocytes and casts, consistent with a
glomerular origin. A 24-h urine collection showed a
protein excretion of 1.8 g/24 h (protein:creatinine ra-
tio 0.25 g/mmol; RR, 0.00–0.03 g/mmol). Abdominal
ultrasound demonstrated mild hepatomegaly with dif-
fuse echogenicity consistent with hepatic steatosis.
The kidneys measured 11.1 cm and 11.4 cm, with no
hydronephrosis. Urine cytology was negative for ma-
lignant cells.
Acute glomerulonephritis was suspected and he was
treated with intravenous methylprednisolone. An urgent
kidney biopsy was performed after platelet transfusion to
a count of 102 × 109/L. A bone marrow biopsy was also
performed. The kidney specimens demonstrated cortex
with 27 glomeruli, of which 6 were globally sclerosed.
The principal abnormality was extensive tubular intra-
luminal erythrocyte cast formation associated with acute
tubular necrosis (Fig. 1). The presence of haemosiderin
deposition within tubular cells was suggestive of recur-
rent glomerular bleeding. There was interstitial fibrosis
and tubular atrophy (approximately 30 %), along with a
mild inflammatory infiltrate without eosinophils or
granulomas. Glomerular capillary loops appeared normal
and there were no segmental necrotizing lesions or
crescents. Immunoperoxidase stains showed weak, non-
specific mesangial staining for IgM (1+) and no signifi-
cant staining for IgA, IgG, C3, C1q and fibrinogen.
Electron microscopy showed thinning of the glomerular
basement membrane but no immune complexes. The
average glomerular basement membrane thickness was
251 ± 70 nm (range, 125–439 nm), consistent with thin
basement membrane disease. This was associated with
incomplete pedicel effacement, indicating podocytopathy
(Fig. 2). Bone marrow examination showed moderately
reduced megakarypoeisis but otherwise normal haemo-
poeitic function. Cytogenetics and immunophenotyping
were unremarkable.
The patient’s macroscopic haematuria ceased after cor-
rection of platelet count and intravenous desmopressin
given for biopsy. The serum creatinine peaked at
552 μmol/L and subsequently improved. He maintained
a good urine output and was discharged for outpatient
follow-up. He achieved a best serum creatinine of
250 μmol/L at 6 months, with significant chronic kidney
disease (eGFR, 25 ml/min) with mild proteinuria (pro-
tein:creatinine ratio, 0.07–0.10 g/mmol). He continued
to experience episodes of macroscopic haematuria and
AKI although not to the extent experienced on initial
admission. His platelet count continued to fluctuate at
26–53 × 109/L. A second bone marrow biopsy 4 months
later only showed mildly reduced megakaryopoiesis. A
reduced production of thrombopoeitin associated with
liver disease and the direct toxic effects of alcohol may
be potential factors contributing to the reduced platelet
production. Repeat serum complement and autoimmune
studies were normal on two separate occasions. After
nine months of ongoing alcohol intake, repeat abdom-
inal ultrasound noted hepatic nodularity and small
volume ascites. The spleen was borderline enlarged,
measuring 14.0 × 7.24 × 6.08 cm, giving a splenic volume
of 323 cm3. Thus, splenic sequestration-destruction
could also be contributing to the thrombocytopaenia.
The follow-up ultrasound also noted a reduction in
kidney size (right 9.4 cm, left 10.2 cm), associated with
Fig. 1 Kidney biopsy showing obstructing tubular red cell casts associated with acute tubular injury (haematoxylin and eosin stain,
magnification × 200). Inset: Perl’s stain demonstrating haemosiderin (blue) accumulation within tubular epithelial cells (magnification × 200)
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an eGFR of 15 ml/min. Due to progression of his
chronic kidney disease, he has been worked up for
long term haemodialysis with the creation of an
arterio-venous fistula.
Discussion
The differential diagnosis of AKI in the setting of
thrombocytopaenia includes infection (e.g. sepsis with
disseminated intravascular coagulation, malaria, lepto-
spirosis), malignant hypertension, autoimmune disease
(e.g. systemic lupus erythematosus), myeloma, drug side-
effect (e.g. ticlodipine) and thrombotic microangiopathy
(e.g. haemolytic-uraemic syndrome, thrombotic throm-
bocytopaenic purpura). In our patient, the clinical, bio-
chemical and serological findings did not support any of
these diagnoses. Infection was unlikely given the absence
of fever, normal C-reactive protein and sterile blood cul-
tures. There was no laboratory evidence of haemolysis
or neurological abnormality to suggest thrombotic mi-
croangiopathy. Rarely, thrombocytopaenia and glomeru-
lar disease can result from mutations in the myosin
heavy chain 9 (MYH9) gene. The MYH9-related disor-
ders are also associated with large platelets (macro-
thrombocytopaenia), leukocyte inclusion bodies and
sensori-neural hearing loss. Our patient had no family
history of renal disease or thrombocytopaenia and was
not hearing impaired. He had morphologically normal
leukocytes and platelets on a standard blood film. The
mean platelet volume was 8.6 fL (RR, 6.5–12.0 fL),
which argues against macrothrombocytopaenia. His
thrombocytopaenia was also a recent development, hav-
ing had a platelet count of 230 × 109/L four years previ-
ously, suggesting an acquired rather than inherited
abnormality.
The association between anticoagulation and haema-
turia is well recognized and may result in AKI through
different mechanisms [1]. A number of case reports have
suggested that an underlying glomerular abnormality
may predispose to warfarin-related nephropathy, including
lupus nephritis [3], focal segmental glomerulosclerosis [4],
IgA nephropathy [5] and thin basement membrane disease
[6]. In the original case series of nine patients reported by
Brodsky et al. on warfarin-related nephropathy, five pa-
tients had mild glomerular immune deposition (of which
three were IgA on immunofluorescence) and one had focal
segmental glomerulosclerosis. However, the status of the
glomerular basement membrane was not mentioned in
that paper [2]. In the absence of coagulopathy, macro-
scopic haematuria with AKI is mostly reported with IgA
nephropathy. Other causes of glomerular haematuria such
Fig. 2 Electron microscopy demonstrating widespread effacement of podocyte foot processes in keeping with a podocytopathy. The glomerular
basement shows considerable variation in calibre, with focal areas of attenuation. The mean thickness of the glomerular basement membrane
was 251 nm (original magnification × 5000)
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as Alport’s syndrome and proliferative glomerulonephriti-
des (e.g. lupus, vasculitis) have not been clearly associated
with macroscopic haematuria-associated AKI [1].
We report a patient with an acquired thrombocyto-
paenia precipitating glomerular haematuria and tubular
injury, who was subsequently discovered to have thin
basement membrane disease on renal biopsy. The mech-
anism of AKI is similar to that described for warfarin-
related nephropathy and IgA nephropathy. Typically,
there is acute tubular injury with prominent obstructive
erythrocyte casts [1, 2]. The incidence of macroscopic
haematuria due to severe thrombocytopaenia in adults is
unclear. In a paediatric retrospective series of 332 chil-
dren with immune thrombocytopaenia over a 10-year
period, 17 % experienced at least one episode of major
haemorrhage, which included a subgroup with macro-
scopic haematuria (6 episodes of macroscopic haema-
turia, 17 episodes of bleeding from multiple sites which
may include haematuria). Major haemorrhage mostly
occurred in patients with platelet counts <20 × 109/L.
Only 13 % of events occurred with platelet counts of
20–75 × 109/L. The nature of the bleeding or presence
of pre-existing kidney disease was not specified [7].
In a prospective observational study of 169 neonates
with platelet counts <60 × 109/L, haematuria was de-
tected in 40 % by dipstick or microscopy [8]. These
paediatric studies suggest that thrombocytopaenia-
associated macroscopic haematuria is rare compared
to microscopic haematuria. However, the source of
the haematuria has not been clearly ascertained in
these studies (glomerular or urological).
In warfarin-treated patients, haematuria may be non-
glomerular (urological) rather than glomerular (war-
farin-related nephropathy), with the risk of haematuria
much higher in over-anticoagulated patients and may be
transient [9]. In thrombocytopaenic patients, there are
certainly case reports demonstrating ureteric bleeding,
with or without associated stone disease [10, 11]. Histo-
logically demonstrable extravasation of erythrocytes
from the bladder capillaries, manifesting as haematuria
with diffuse submucosal petechiae on cystoscopy has
been described in a patient with immune-mediated
thrombocytopaenia (platelet count 33 × 109/L) [12]. The
evidence for glomerular haematuria in thrombocytopae-
nic patients, however, is lacking. Thus, this is a unique
case report which histologically demonstrates glomerular
haematuria-associated AKI in the setting of severe
thrombocytopaenia.
There is also strong epidemiological evidence that AKI
is associated with the development and progression of
chronic kidney disease. This has also been suggested by
studies of warfarin-related nephropathy [13]. The con-
cern of recurrent AKI begs the question of how aggres-
sive clinicians should treat severe thrombocytopaenia in
patients with an underlying risk factor for glomerular
haematuria. Thin basement membrane disease has trad-
itionally been considered a relatively benign condition
but recurrent episodes of AKI related to macroscopic
haematuria may be considered a risk factor for chronic
kidney disease progression and end-stage renal failure.
Conclusions
Haematuria in the setting of severe thrombocytopaenia
may be glomerular or non-glomerular in origin. Given
the rarity of AKI from glomerular haematuria with plate-
let counts >20 × 109/L, an underlying glomerular abnor-
mality such as thin basement membrane disease should
be considered. Heavy glomerular bleeding may result in
recurrent AKI and progression of chronic kidney disease
in patients with thin basement membrane disease.
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